The Apex Times
Above the Noise
Business Wire
BusinessJPMorgan Lowers Ford Price Target to $16, Still Sees 33% Upside Despite Stock’s SlideThe Apex TimesBusinessJamie Dimon Warns U.S. Growth Still Holds, But Risks Are “Shifting Under The Surface” as JPM Shares RiseThe Apex TimesBusinessJPMorgan trims share buybacks in the third quarter, Dimon saysThe Apex TimesBusinessFutures Mixed as Earnings Season Turns Busy, With UnitedHealth Lifting the Dow and Memory Stocks Under PressureThe Apex TimesBusinessJohnson & Johnson tops earnings expectations in Q3, revenue miss outlines mixed demand pictureThe Apex TimesBusinessPivotal points to Meta’s new Muse Wonder AI model launch, citing potential 25% upside for METAThe Apex TimesBusinessSolarEdge power hardware gets spotlight inside NVIDIA’s AI Factory MGX ecosystem showcaseThe Apex TimesBusinessUnitedHealth shares rise after third-quarter profit beat and a higher 2026 outlookThe Apex TimesBusinessBofA survey finds global fund managers have the biggest tech overweight since August 2020The Apex TimesBusinessAhead of earnings, Wall Street watches wealth, assets and custody at Morgan Stanley, BlackRock and State StreetThe Apex TimesBusinessOpinion: Nvidia and Broadcom can both profit from AI infrastructure buildout, but their roles differThe Apex TimesBusinessBernstein downgrades AT&T to Market Perform, citing competitive pressure tied to SpaceXThe Apex TimesBusinessJPMorgan Lowers Ford Price Target to $16, Still Sees 33% Upside Despite Stock’s SlideThe Apex TimesBusinessJamie Dimon Warns U.S. Growth Still Holds, But Risks Are “Shifting Under The Surface” as JPM Shares RiseThe Apex TimesBusinessJPMorgan trims share buybacks in the third quarter, Dimon saysThe Apex TimesBusinessFutures Mixed as Earnings Season Turns Busy, With UnitedHealth Lifting the Dow and Memory Stocks Under PressureThe Apex TimesBusinessJohnson & Johnson tops earnings expectations in Q3, revenue miss outlines mixed demand pictureThe Apex TimesBusinessPivotal points to Meta’s new Muse Wonder AI model launch, citing potential 25% upside for METAThe Apex TimesBusinessSolarEdge power hardware gets spotlight inside NVIDIA’s AI Factory MGX ecosystem showcaseThe Apex TimesBusinessUnitedHealth shares rise after third-quarter profit beat and a higher 2026 outlookThe Apex TimesBusinessBofA survey finds global fund managers have the biggest tech overweight since August 2020The Apex TimesBusinessAhead of earnings, Wall Street watches wealth, assets and custody at Morgan Stanley, BlackRock and State StreetThe Apex TimesBusinessOpinion: Nvidia and Broadcom can both profit from AI infrastructure buildout, but their roles differThe Apex TimesBusinessBernstein downgrades AT&T to Market Perform, citing competitive pressure tied to SpaceXThe Apex TimesBusinessJPMorgan Lowers Ford Price Target to $16, Still Sees 33% Upside Despite Stock’s SlideThe Apex TimesBusinessJamie Dimon Warns U.S. Growth Still Holds, But Risks Are “Shifting Under The Surface” as JPM Shares RiseThe Apex TimesBusinessJPMorgan trims share buybacks in the third quarter, Dimon saysThe Apex TimesBusinessFutures Mixed as Earnings Season Turns Busy, With UnitedHealth Lifting the Dow and Memory Stocks Under PressureThe Apex TimesBusinessJohnson & Johnson tops earnings expectations in Q3, revenue miss outlines mixed demand pictureThe Apex TimesBusinessPivotal points to Meta’s new Muse Wonder AI model launch, citing potential 25% upside for METAThe Apex TimesBusinessSolarEdge power hardware gets spotlight inside NVIDIA’s AI Factory MGX ecosystem showcaseThe Apex TimesBusinessUnitedHealth shares rise after third-quarter profit beat and a higher 2026 outlookThe Apex TimesBusinessBofA survey finds global fund managers have the biggest tech overweight since August 2020The Apex TimesBusinessAhead of earnings, Wall Street watches wealth, assets and custody at Morgan Stanley, BlackRock and State StreetThe Apex TimesBusinessOpinion: Nvidia and Broadcom can both profit from AI infrastructure buildout, but their roles differThe Apex TimesBusinessBernstein downgrades AT&T to Market Perform, citing competitive pressure tied to SpaceXThe Apex TimesBusinessJPMorgan Lowers Ford Price Target to $16, Still Sees 33% Upside Despite Stock’s SlideThe Apex TimesBusinessJamie Dimon Warns U.S. Growth Still Holds, But Risks Are “Shifting Under The Surface” as JPM Shares RiseThe Apex TimesBusinessJPMorgan trims share buybacks in the third quarter, Dimon saysThe Apex TimesBusinessFutures Mixed as Earnings Season Turns Busy, With UnitedHealth Lifting the Dow and Memory Stocks Under PressureThe Apex TimesBusinessJohnson & Johnson tops earnings expectations in Q3, revenue miss outlines mixed demand pictureThe Apex TimesBusinessPivotal points to Meta’s new Muse Wonder AI model launch, citing potential 25% upside for METAThe Apex TimesBusinessSolarEdge power hardware gets spotlight inside NVIDIA’s AI Factory MGX ecosystem showcaseThe Apex TimesBusinessUnitedHealth shares rise after third-quarter profit beat and a higher 2026 outlookThe Apex TimesBusinessBofA survey finds global fund managers have the biggest tech overweight since August 2020The Apex TimesBusinessAhead of earnings, Wall Street watches wealth, assets and custody at Morgan Stanley, BlackRock and State StreetThe Apex TimesBusinessOpinion: Nvidia and Broadcom can both profit from AI infrastructure buildout, but their roles differThe Apex TimesBusinessBernstein downgrades AT&T to Market Perform, citing competitive pressure tied to SpaceXThe Apex Times
Back to front
Johnson & Johnson reports third-quarter profit of $210 million, 9 cents per share
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 13, 6:56 AM EDT

Johnson & Johnson reports third-quarter profit of $210 million, 9 cents per share

In a brief earnings snapshot posted on Tuesday, Johnson & Johnson said it earned $210 million in its third quarter, equivalent to 9 cents per share.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Johnson & Johnson reported third-quarter profit of $210 million, according to an earnings snapshot published Tuesday by Yahoo Finance.

On a per-share basis, the New Brunswick, New Jersey-based company said its profit was 9 cents for the quarter.

The update did not provide additional breakdowns such as revenue, operating income, segment performance, or comparisons to the same quarter a year earlier. It also did not include details on whether results were driven by specific product categories, cost changes, or one-time items.

Earnings snapshots like this typically serve as a quick headline summary of a company’s quarterly financial outcome, translating net profit into an earnings-per-share figure that investors and analysts can use for immediate tracking against expectations. In this case, Johnson & Johnson’s headline earnings-per-share was 9 cents.

The company’s profit figure is presented as a single aggregated result for the quarter. Without more disclosures in the posted snapshot, it is not possible to determine how underlying business trends compared with the prior quarter, or how financial performance varied across Johnson & Johnson’s operations.

From a market perspective, investors often look beyond a single profit number to the drivers behind it, including whether growth or margin changes came from recurring sales, pricing, manufacturing costs, or restructuring. The snapshot provided Tuesday did not include those context points, limiting what can be concluded from the reported $210 million profit and 9 cents per share alone.

A key caveat for readers is that the earnings snapshot does not indicate guidance for future quarters, cash flow results, debt or share repurchase activity, or whether Johnson & Johnson faced any material legal or regulatory developments during the period. Those items, which frequently move sentiment around large healthcare companies, were not addressed in the brief report.

Why It Matters

  • The reported profit and earnings-per-share figure provide a baseline for how Johnson & Johnson performed in the quarter, but the lack of supporting details restricts interpretation.
  • Without revenue, margin, and segment information, investors may need to wait for fuller reporting to understand the drivers behind the profit result.
  • The snapshot format suggests a quick market headline rather than comprehensive results, so market reaction could depend on how additional disclosures confirm or explain the headline numbers.

Sources

Key Facts

  • Johnson & Johnson reported third-quarter profit of $210 million.
  • On a per-share basis, the company reported profit of 9 cents for the quarter.
  • The update described Johnson & Johnson as being based in New Brunswick, New Jersey.
  • The published snapshot did not include additional financial line items or year-over-year comparisons.

Healthcare Related